Ming-Ling Chang is an expert in Hepatology at Chang Gung Memorial Hospital (Taiwan). As of October 2026, ScienceLeadR ranks Ming-Ling Chang in the top 1% of experts worldwide for Hepatitis. Ming-Ling Chang has authored 171 publications, the most recent in 2026, and is an investigator in 3 clinical trials. SLR score: 542 (community average: 125). How the SLR is computed.

LeadR Profile

Ming-Ling Chang Chang Gung Memorial Hospital Taiwan
542 ScienceLeadR Reputation 542
Network Map

Hepatology

Subspecialties: Gastroenterology - Biochemistry - Endocrinology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2005 - 2026

Source: PubMed

Chang Gung Memorial Hospital

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 171

Citations

Citations: 2 647 1st author: 55 Last author: 25 Unique author: 2


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Rifaximin Versus Norfloxacin for Secondary Prophylaxis of Spontaneous Bacterial Peritonitis in the Era of Antimicrobial Resistance: A Systematic Review and Meta-Analysis with Missing-Data Sensitivity Analyses.
PMID 42940091 — peritonitis, norfloxacin, rifaximin
Biomedicines20260
Taiwan GEST-TASL-TMASO Joint Position Statement in Managing Metabolic Dysfunction-Associated Steatotic Liver Disease and Obesity.
PMID 42922180 — liver diseases, fibrosis, non-alcoholic fatty liver disease, liver, bariatric surgery, prevalence, obesity, precision medicine, gastrointestinal microbiome
Liver Int20260
Characteristic geoepidemiology and phenotype of autoimmune hepatitis: an 8-year population-based study in Taiwan.
PMID 42848155 — liver diseases, diabetes mellitus, hepatitis, autoimmune, mortality, hyperlipidemias, incidence, income, phenotype, liver, prevalence, sex, hepatitis
Hepatol Int20260
Gut Microbiota Recovery After Direct-Acting Antiviral Therapy for Chronic Hepatitis C: A Systematic Review and Meta-Analysis.
PMID 42655187 — dysbiosis, hepatitis c, chronic, hepatitis c, recycling, hepatitis, chronic, therapeutics, gastrointestinal microbiome, antiviral agents, microbiota, hepatitis
Microorganisms20260
Pulmonary Vascular Permeability and Extravascular Lung Water Index Vary with Infection Site in Patients with Liver Cirrhosis and Septic Shock.
PMID 42652816 — pulmonary edema, mortality, lung, liver cirrhosis, shock, septic, liver, pneumonia, edema, infections
J Clin Med20260

Clinical Studies 3

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 2
Phase 4 1

By status:

Unknown 2
Completed 1

By type:

Observational 2
Interventional 1

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 0
multicentric5to9 0
multicentricup10 0

Main Topics

LeadR Networks

Main global connection map